Form 4 for SER Serina Therapeutics, Inc.

Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-15 · accession 0001493152-24-033277 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-08-20	2024-08-15+	SER	Bailey Gregory	Dir	P - Purchase	$7.30	+19.2K	45.8K	+72%	+$140.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-08-16	P	A	6,400	$7.31	39,406	D	—	—	(F2) The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.12 per share to a high of $8.02 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
2	Common	Common Stock	2024-08-15	P	A	6,400	$6.65	33,006	D	—	—	(F1) The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.55 per share to a high of $7.94 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
3	Common	Common Stock	2024-08-19	P	A	6,400	$7.93	45,806	D	—	—	(F3) The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.24 per share to a high of $8.57 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.